Skip to main content

4 articles related to "Hdl Subclasses"

No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.
No matches to your query could be found. Try another search term.

Articles

Original Research

Published on 24 Feb 2023

Alterations in circulating lipidomic profile in patients with type 2 diabetes with or without non-alcoholic fatty liver disease

in Metabolomics

Assim A. Alfadda
Abdulrahman M. Almaghamsi
Suphia Murad Sherbeeni
Adel N. Alqutub
Abdullah S. Aldosary
Arthur C. Isnani
Nasser Al-Daghri
Simon D. Taylor-Robinson
Rukhsana Gul

Frontiers in Molecular Biosciences

doi 10.3389/fmolb.2023.1030661

4,015 views
5 citations

Review

Published on 22 Jan 2018

Pharmacological Intervention to Modulate HDL: What Do We Target?

in Cardiovascular and Smooth Muscle Pharmacology

Nicholas J. Woudberg
Sarah Pedretti
Sandrine Lecour
Rainer Schulz
Nicolas Vuilleumier
Richard W. James
Miguel A. Frias

Frontiers in Pharmacology

doi 10.3389/fphar.2017.00989

14,423 views
73 citations

Original Research

Published on 30 Oct 2023

Analysis of redox status and HDL subclasses in patients with lymphoma and the associations with FDG-PET/CT findings

in Hematologic Malignancies

Bosa Mirjanic-Azaric
Sinisa Stankovic
Lana Nezic
Zana Radic Savic
Dragana Malcic- Zanic
Ranko Skrbic
Jelena Kotur-Stevuljevic
Natasa Bogavac-Stanojevic

Frontiers in Oncology

doi 10.3389/fonc.2023.1221414

2,617 views
2 citations

Original Research

Published on 29 Jun 2022

ANGPTL3 Is Involved in the Post-prandial Response in Triglyceride-Rich Lipoproteins and HDL Components in Patients With Coronary Artery Disease

in Lipids in Cardiovascular Disease

Xin Guo
Zhijie Huang
Jin Chen
Jiarui Hu
Die Hu
Daoquan Peng
Bilian Yu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2022.913363

3,777 views
1 citation